Skip to main navigation Skip to search Skip to main content

Thrombolytic therapy of a stenosed coronary vein bypass graft with continuous intragraft streptokinase drip

  • Morris Mosseri
  • , Yonathan Hasin
  • , Dan Admon
  • , Mervyn S. Gotsman*
  • *Corresponding author for this work
  • Hadassah University Medical Centre

Research output: Contribution to journalArticlepeer-review

Abstract

A patient with newly onset angina due to recent thrombotic occlusion of a saphenous vein graft to the left anterior descending coronary artery is described. The patient was successfully treated by a direct intragraft infusion of streptokinase (STK) followed by a continuous intragraft infusion of an additional 1.5 million units of STK during the next 20 h through a regular diagnostic catheter. The patient was discharged on oral anticoagulant treatment with remarkable relief of the angina. Repeat angiography showed complete dissolution of the graft thrombus. This patient demonstrates that continuous infusion of STK into a saphenous vein graft is an effective treatment for recently formed thrombi.

Original languageEnglish
Pages (from-to)318-321
Number of pages4
JournalCardiology (Switzerland)
Volume77
Issue number4
DOIs
StatePublished - 1990
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Fibrinolysis
  • Graft occlusion
  • Saphenous vein

Fingerprint

Dive into the research topics of 'Thrombolytic therapy of a stenosed coronary vein bypass graft with continuous intragraft streptokinase drip'. Together they form a unique fingerprint.

Cite this